<DOC>
	<DOCNO>NCT00498927</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , temozolomide , work different way stop growth tumor cell , either kill cell stop dividing . PURPOSE : This phase II trial study well temozolomide work treat patient recurrent glioblastoma multiforme malignant glioma .</brief_summary>
	<brief_title>Temozolomide Treating Patients With Recurrent Glioblastoma Multiforme Other Malignant Glioma</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine progression-free survival rate 6 month patient recurrent glioblastoma multiforme malignant glioma treat temozolomide . Secondary - Determine overall survival patient treated drug . OUTLINE : Patients receive oral temozolomide daily absence disease progression unacceptable toxicity . Blood sample collect baseline every 2 month 2 year evaluation marker neo-angiogenesis . Samples analyze protein expression , reverse-transcriptase PCR , ELISA , western blot . ( Samples longer collect tested 1/12/09 )</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Pathologically diagnose glioblastoma multiforme malignant glioma Recurrent disease Must receive prior temozolomide PATIENT CHARACTERISTICS : Karnofsky performance status 60100 % Granulocyte count ≥ 1,500/mm³ Platelet count ≥ 100,000/mm³ SGOT ≤ 2.5 time upper limit normal ( ULN ) Creatinine ≤ 2 time ULN Bilirubin ≤ 2 time ULN No active malignancy except cervical carcinoma situ basal cell carcinoma skin No serious medical psychiatric illness , opinion investigator , would preclude study treatment No medical condition precludes swallow pill Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : See Disease Characteristics Recovered prior therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult diffuse astrocytoma</keyword>
	<keyword>adult pilocytic astrocytoma</keyword>
	<keyword>adult subependymal giant cell astrocytoma</keyword>
	<keyword>adult anaplastic ependymoma</keyword>
	<keyword>adult ependymoma</keyword>
	<keyword>adult myxopapillary ependymoma</keyword>
	<keyword>adult subependymoma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult oligodendroglioma</keyword>
	<keyword>adult brain stem glioma</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>adult pineal gland astrocytoma</keyword>
</DOC>